tiprankstipranks
Trending News
More News >

Camurus Reports Strong Q1 2025 Performance with Significant Revenue Growth

Story Highlights
Camurus Reports Strong Q1 2025 Performance with Significant Revenue Growth

Confident Investing Starts Here:

The latest announcement is out from Camurus AB ( (SE:CAMX) ).

Camurus reported a strong first quarter in 2025, with total revenues increasing by 43% to SEK 558 million and product sales rising by 33% to SEK 485 million. The company also saw a significant 162% rise in profit before tax. Key developments included regulatory approval for Buvidal in Serbia and new launches in Switzerland and Luxembourg, along with the initiation of a Phase 1 clinical study for a new semaglutide depot. The positive CHMP opinion for Oczyesa® in the EU marks a significant advancement for Camurus, potentially enhancing its market positioning and stakeholder value.

The most recent analyst rating on (SE:CAMX) stock is a Buy with a SEK750.00 price target. To see the full list of analyst forecasts on Camurus AB stock, see the SE:CAMX Stock Forecast page.

More about Camurus AB

Camurus is an international biopharmaceutical company focused on developing and commercializing innovative long-acting medicines for severe and chronic diseases. Utilizing its proprietary FluidCrystal® technology, Camurus has a robust R&D pipeline targeting dependence, pain, cancer, and endocrine diseases. The company operates in Europe, the US, and Australia, with headquarters in Lund, Sweden, and is listed on Nasdaq Stockholm under the ticker CAMX.

Average Trading Volume: 75,248

Current Market Cap: SEK36.83B

Learn more about CAMX stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App